Some people who work at big companies sometimes buy their own company's stock. This is called an insider trade. When they do this, it can mean that they think the stock will go up in value or they think the stock is a good price to buy. It doesn't always happen, but when it does, we can look at these trades and see if they give us any clues about which stocks might be a good idea to invest in. Read from source...

- The article title is misleading and clickbait, as it suggests that the insider purchases are related to a $6.5M bet on a healthcare stock, but does not reveal which one or provide any evidence for such a claim.
- The article body repeats the same information about insider trades without providing any context, analysis, or explanation of why they are significant or relevant for investors or traders. It also fails to disclose the potential conflicts of interest that may arise from insiders buying or selling their own company's shares.
- The article ends abruptly with a promotion for Benzinga Pro, which is an inappropriate and irrelevant way to conclude an informative and persuasive piece of content. It also implies that the only reason for writing the article was to generate leads for the subscription service, rather than to educate or inform readers about insider trading activities.
- The article does not follow any journalistic standards or ethics, as it lacks credibility, accuracy, objectivity, and fairness. It also violates Benzinga's own policy on disclosing conflicts of interest and providing transparent reporting on insider transactions.